Search research articles
Contact Us
Filters
Showing results (71-80 of 90) with videos related to
Page
of 9
Sort By:
Neurology
|
September 4, 2015
Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies
Catherine Labbé, Kotaro Ogaki, Oswaldo Lorenzo-Betancor, et al.
JAMA Neurology
|
November 18, 2014
Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease
Lorraine V Kalia, Anthony E Lang, Lili-Naz Hazrati, et al.
Annals of Neurology
|
March 11, 2011
Independent and joint effects of the MAPT and SNCA genes in Parkinson disease
Alexis Elbaz, Owen A Ross, John P A Ioannidis, et al.
Plos One
|
September 7, 2012
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research
Selina Wray, Matthew Self, , et al.
Neurology
|
October 19, 2014
Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease
Jessie Theuns, Aline Verstraeten, Kristel Sleegers, et al.
Science Translational Medicine
|
October 22, 2020
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3
Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West, et al.
The Lancet. Neurology
|
September 3, 2011
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study
Owen A Ross, Alexandra I Soto-Ortolaza, Michael G Heckman, et al.
The Lancet. Neurology
|
June 12, 2018
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study
Marialuisa Quadri, Wim Mandemakers, Martyna M Grochowska, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 6, 2013
Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium
Michael G Heckman, Alexandra I Soto-Ortolaza, Jan O Aasly, et al.
NPJ Parkinson'S Disease
|
May 28, 2026
Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset
Katalin Vincze, Agnieszka Szwajda, Alexander Ploner, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 90) with videos related to
Sort By:
Page
of 9
Neurology
|
September 4, 2015
Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies
Catherine Labbé, Kotaro Ogaki, Oswaldo Lorenzo-Betancor, et al.
JAMA Neurology
|
November 18, 2014
Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease
Lorraine V Kalia, Anthony E Lang, Lili-Naz Hazrati, et al.
Annals of Neurology
|
March 11, 2011
Independent and joint effects of the MAPT and SNCA genes in Parkinson disease
Alexis Elbaz, Owen A Ross, John P A Ioannidis, et al.
Plos One
|
September 7, 2012
Creation of an open-access, mutation-defined fibroblast resource for neurological disease research
Selina Wray, Matthew Self, , et al.
Neurology
|
October 19, 2014
Global investigation and meta-analysis of the C9orf72 (G4C2)n repeat in Parkinson disease
Jessie Theuns, Aline Verstraeten, Kristel Sleegers, et al.
Science Translational Medicine
|
October 22, 2020
Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3
Mercedes Prudencio, Hector Garcia-Moreno, Karen R Jansen-West, et al.
The Lancet. Neurology
|
September 3, 2011
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study
Owen A Ross, Alexandra I Soto-Ortolaza, Michael G Heckman, et al.
The Lancet. Neurology
|
June 12, 2018
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study
Marialuisa Quadri, Wim Mandemakers, Martyna M Grochowska, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
August 6, 2013
Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium
Michael G Heckman, Alexandra I Soto-Ortolaza, Jan O Aasly, et al.
NPJ Parkinson'S Disease
|
May 28, 2026
Genetic variation in antidiabetic drug targets: associations with Parkinson's disease risk and age at onset
Katalin Vincze, Agnieszka Szwajda, Alexander Ploner, et al.
Page
of 9